HRP20120046T1 - Nerameksan za uporabu kod liječenja subakutnog tinitusa - Google Patents

Nerameksan za uporabu kod liječenja subakutnog tinitusa Download PDF

Info

Publication number: HRP20120046T1
Authority: HR; Croatia
Prior art keywords: neramexane; pharmaceutically acceptable; acceptable salt; use according; tinnitus
Prior art date: 2007-09-12

Application number

HR20120046T

Other languages

English (en)

Croatian (hr)

Inventor

Ellers-Lenz Barbara

Rosenberg Tanja

Krueger Hagen

Althaus Michael

Original Assignee

Merz Pharma Gmbh & Co. Kgaa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-12

Filing date

2008-09-10

Publication date

2012-02-29

2008-09-10 Application filed by Merz Pharma Gmbh & Co. Kgaa filed Critical Merz Pharma Gmbh & Co. Kgaa

2012-02-29 Publication of HRP20120046T1 publication Critical patent/HRP20120046T1/hr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Otolaryngology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Percussion Or Vibration Massage (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

HR20120046T 2007-09-12 2008-09-10 Nerameksan za uporabu kod liječenja subakutnog tinitusa HRP20120046T1 (hr)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
US99339607P	2007-09-12	2007-09-12
EP07253630		2007-09-12
US6702608P	2008-02-25	2008-02-25
US6693108P	2008-02-25	2008-02-25
US6708308P	2008-02-25	2008-02-25
EP08004778		2008-03-14
EP08004777		2008-03-14
EP08004776		2008-03-14
PCT/EP2008/007421 WO2009033652A1 (en)	2007-09-12	2008-09-10	1-amino-alkylcyclohexane derivatives for the treatment of cochlear tinnitus

Publications (1)

Publication Number	Publication Date
HRP20120046T1 true HRP20120046T1 (hr)	2012-02-29

Family

ID=40451596

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20120046T HRP20120046T1 (hr)	2007-09-12	2008-09-10	Nerameksan za uporabu kod liječenja subakutnog tinitusa

Country Status (21)

Country	Link
US (6)	US9498450B2 (de)
EP (6)	EP2200600B1 (de)
JP (6)	JP5563461B2 (de)
KR (4)	KR20100052556A (de)
CN (4)	CN101801365A (de)
AR (3)	AR070025A1 (de)
AT (1)	ATE532507T1 (de)
AU (4)	AU2008298015B2 (de)
BR (2)	BRPI0816712A2 (de)
CA (4)	CA2699207A1 (de)
DK (1)	DK2200600T3 (de)
ES (5)	ES2596262T3 (de)
HR (1)	HRP20120046T1 (de)
MX (4)	MX2010002733A (de)
PL (1)	PL2200600T3 (de)
PT (1)	PT2200600E (de)
RU (1)	RU2011137131A (de)
SI (1)	SI2200600T1 (de)
TW (3)	TW200922544A (de)
WO (4)	WO2009033652A1 (de)
ZA (4)	ZA201001264B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200922544A (en) *	2007-09-12	2009-06-01	Merz Pharma Gmbh & Amp Co Kgaa	Interval therapy for the treatment of tinnitus
US20110294890A1 (en) *	2010-05-28	2011-12-01	Merz Pharma Gmbh & Co. Kgaa	Neramexane for the treatment or prevention of inner ear disorders
EP2585049A1 (de)	2010-06-24	2013-05-01	Merz Pharma GmbH & Co. KGaA	Darreichungsform von neramexan in mehreren einheiten
JP6084931B2 (ja) *	2011-01-20	2017-02-22	メルツファーマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフトアウフアクティーン	ストレス又は急性聴力損失に関連する耳鳴の治療又は予防のためのネラメキサン
AU2014225534A1 (en) *	2013-03-06	2015-09-24	Acorda Therapeutics, Inc.	Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure
EA201692163A1 (ru) *	2014-04-28	2017-03-31	Керин Фармасьютикал Ко., Лтд.	Лекарственное средство для лечения пациентов с тиннитусом
EA201692164A1 (ru) *	2014-04-28	2017-03-31	Керин Фармасьютикал Ко., Лтд.	Лекарственное средство для лечения пациентов с тиннитусом
CA2999467C (en) *	2014-10-23	2023-10-10	Arena Pharmaceuticals, Inc.	Method of treating conditions related to the pgi2 receptor
HUE056138T2 (hu) *	2015-05-18	2022-01-28	Sensorion	Azasetron a halláskárosodás kezelésében való felhasználásra
KR101893604B1 (ko)	2015-08-27	2018-08-30	경희대학교 산학협력단	칸디다 유틸리스 추출물을 포함하는 난청의 예방 또는 치료용 조성물
CN105924362B (zh) *	2016-02-05	2018-08-17	上海龙翔生物医药开发有限公司	芳香环丙基胺类化合物、其药学上可接受的盐、其制备方法及其用途
WO2018160882A1 (en)	2017-03-01	2018-09-07	Arena Pharmaceuticals, Inc.	Compositions comprising pgi2-receptor agonists and processes for the preparation thereof
KR102268893B1 (ko)	2020-01-16	2021-06-24	경북대학교 산학협력단	림노트릭스 속 knua002 균주를 포함하는 난청의 예방 또는 치료용 조성물
CN111477199B (zh) *	2020-04-02	2021-11-30	北京瑞迪欧文化传播有限责任公司	一种嵌入式音乐控制系统
EP4297708A4 (de) *	2021-09-09	2024-08-28	Samsung Electronics Co., Ltd.	Verwaltung der bereitstellung von audioinhalten

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6024983A (en)	1986-10-24	2000-02-15	Southern Research Institute	Composition for delivering bioactive agents for immune response and its preparation
US4849222A (en)	1987-03-24	1989-07-18	The Procter & Gamble Company	Mixtures for treating hypercholesterolemia
JP2670680B2 (ja)	1988-02-24	1997-10-29	株式会社ビーエムジー	生理活性物質含有ポリ乳酸系微小球およびその製造法
US5288502A (en)	1991-10-16	1994-02-22	The University Of Texas System	Preparation and uses of multi-phase microspheres
DE69431404T2 (de)	1993-10-22	2003-04-30	Genentech Inc., San Francisco	Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe
DE19528388A1 (de) *	1995-08-02	1997-02-06	Hans Peter Prof Dr Med Zenner	Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
WO1998010757A2 (en) *	1996-09-11	1998-03-19	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	The use of functional n-methyl-d-aspartate antagonists to ameliorate or prevent aminoglycoside-induced ototoxicity
JP3963488B2 (ja) *	1997-06-30	2007-08-22	メルツファーマゲゼルシャフトミットベシュレンクテルハフツンクウントコンパニーコマンディゲゼルシャフトアウフアクチェン	１−アミノ−アルキルシクロヘキサンｎｍｄａ受容体拮抗薬
US6071966A (en) *	1997-06-30	2000-06-06	Merz + Co. Gmbh & Co.	1-amino-alkylcyclohexane NMDA receptor antagonists
HUP0300600A2 (hu) *	2000-04-26	2003-08-28	Warner-Lambert Co.	Ciklohexil-amin-származékok mint altípus-szelektív NMDA receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
DE10048969A1 (de) *	2000-08-23	2002-03-14	Mueller Schwefe Gerhard	Verwendung von Flupirtin zur Tinnitusbehandlung
US20030236288A1 (en) *	2002-02-28	2003-12-25	Karl Schoenafinger	Use of substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadizol-2-ones for inhibiting pancreatic lipase
JP2004021734A (ja)	2002-06-18	2004-01-22	Nokia Corp	キーパッドおよびキーパッドシステム
US7086532B2 (en) *	2003-07-16	2006-08-08	Allergan, Inc.	Titration/compliance pack with increasing doses
JP2006502158A (ja) *	2002-09-06	2006-01-19	デュレクトコーポレーション	グルタメート媒介神経伝達のモジュレーターの内耳への送達
DE10252665A1 (de)	2002-11-11	2004-06-03	Grünenthal GmbH	4-Aminomethyl-1-aryl-cyclohexylamin-Derivate
US20050014743A1 (en) *	2003-05-27	2005-01-20	Forest Laboratories, Inc.	Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
AR046314A1 (es)	2003-11-05	2005-11-30	Merz Pharma Gmbh & Co Kgaa	Composiciones que comprenden ciclohexilaminas y aminoadamantanos
US20060002999A1 (en)	2004-06-17	2006-01-05	Forest Laboratories, Inc.	Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
ES2483126T3 (es) *	2004-06-17	2014-08-05	Merz Pharma Gmbh & Co. Kgaa	Formulaciones de formas de dosificación de neramexano
US20060205822A1 (en)	2004-12-22	2006-09-14	Forest Laboratories, Inc.	1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
EP1861161A4 (de) *	2005-01-24	2012-05-16	Neurosystec Corp	Vorrichtung und verfahren zur abgabe therapeutischer und/oder anderer mittel im innenohr und an andere gewebe
US20060205789A1 (en) *	2005-03-04	2006-09-14	Neurosystec Corporation	Gacyclidine formulations
TWI265036B (en) *	2005-04-29	2006-11-01	Guo-Ming Huang	Safety injector and method of operating the same
EP1898848B1 (de) *	2005-05-18	2010-11-24	GT Urological, LLC	Wirkstoffeluierung für implantierbare inkontinenzgeräte
CN1896729A (zh)	2005-07-15	2007-01-17	复旦大学附属中山医院	纳米药物自组装双稳态量子线阵列及其制备方法
US20070141148A1 (en)	2005-11-30	2007-06-21	Merz Pharma Gmbh & Co. Kgaa	Neramexane MR matrix tablet
TW200819458A (en) *	2006-06-23	2008-05-01	Merz Pharma Gmbh & Co Kgaa	Metabotropic glutamate receptor modulators
TW200922544A (en) *	2007-09-12	2009-06-01	Merz Pharma Gmbh & Amp Co Kgaa	Interval therapy for the treatment of tinnitus
TW201010691A (en) *	2008-06-12	2010-03-16	Merz Pharma Gmbh & Co Kgaa	1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
TW201006463A (en) *	2008-06-26	2010-02-16	Merz Pharma Gmbh & Co Kgaa	Pharmaceutical compositions comprising aminocyclohexane derivatives
AU2009291244A1 (en) *	2008-09-10	2010-03-18	Merz Pharma Gmbh & Co. Kgaa	1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus
US20110294890A1 (en) *	2010-05-28	2011-12-01	Merz Pharma Gmbh & Co. Kgaa	Neramexane for the treatment or prevention of inner ear disorders
JP6084931B2 (ja) *	2011-01-20	2017-02-22	メルツファーマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフトアウフアクティーン	ストレス又は急性聴力損失に関連する耳鳴の治療又は予防のためのネラメキサン

2008
- 2008-09-10 TW TW097134705A patent/TW200922544A/zh unknown
- 2008-09-10 US US12/733,646 patent/US9498450B2/en not_active Expired - Fee Related
- 2008-09-10 AR ARP080103936A patent/AR070025A1/es not_active Application Discontinuation
- 2008-09-10 EP EP08801987A patent/EP2200600B1/de active Active
- 2008-09-10 JP JP2010524395A patent/JP5563461B2/ja not_active Expired - Fee Related
- 2008-09-10 CN CN200880106925A patent/CN101801365A/zh active Pending
- 2008-09-10 JP JP2010524394A patent/JP5563460B2/ja not_active Expired - Fee Related
- 2008-09-10 JP JP2010524392A patent/JP5613053B2/ja not_active Expired - Fee Related
- 2008-09-10 MX MX2010002733A patent/MX2010002733A/es not_active Application Discontinuation
- 2008-09-10 KR KR1020107007786A patent/KR20100052556A/ko not_active Ceased
- 2008-09-10 ES ES11005567.0T patent/ES2596262T3/es active Active
- 2008-09-10 US US12/733,577 patent/US20110086916A1/en not_active Abandoned
- 2008-09-10 CA CA2699207A patent/CA2699207A1/en not_active Abandoned
- 2008-09-10 US US12/733,582 patent/US9468610B2/en not_active Expired - Fee Related
- 2008-09-10 KR KR1020107007787A patent/KR20100052557A/ko not_active Ceased
- 2008-09-10 ES ES08801987T patent/ES2377253T3/es active Active
- 2008-09-10 DK DK08801987.2T patent/DK2200600T3/da active
- 2008-09-10 AT AT08801987T patent/ATE532507T1/de active
- 2008-09-10 WO PCT/EP2008/007421 patent/WO2009033652A1/en active Application Filing
- 2008-09-10 KR KR1020107007795A patent/KR20100052559A/ko not_active Ceased
- 2008-09-10 WO PCT/EP2008/007419 patent/WO2009033650A1/en active Application Filing
- 2008-09-10 EP EP11005567.0A patent/EP2386299B1/de active Active
- 2008-09-10 PT PT08801987T patent/PT2200600E/pt unknown
- 2008-09-10 AR ARP080103937A patent/AR070026A1/es not_active Application Discontinuation
- 2008-09-10 EP EP08801986.4A patent/EP2203163B1/de active Active
- 2008-09-10 BR BRPI0816712A patent/BRPI0816712A2/pt not_active IP Right Cessation
- 2008-09-10 EP EP08801985.6A patent/EP2200599B1/de active Active
- 2008-09-10 CA CA2699209A patent/CA2699209A1/en not_active Abandoned
- 2008-09-10 PL PL08801987T patent/PL2200600T3/pl unknown
- 2008-09-10 WO PCT/EP2008/007420 patent/WO2009033651A1/en active Application Filing
- 2008-09-10 BR BRPI0816690A patent/BRPI0816690A2/pt not_active IP Right Cessation
- 2008-09-10 CN CN200880106404A patent/CN101835469A/zh active Pending
- 2008-09-10 HR HR20120046T patent/HRP20120046T1/hr unknown
- 2008-09-10 CN CN200880106973A patent/CN101801366A/zh active Pending
- 2008-09-10 KR KR1020107007793A patent/KR20100052558A/ko not_active Ceased
- 2008-09-10 AU AU2008298015A patent/AU2008298015B2/en not_active Ceased
- 2008-09-10 AU AU2008298017A patent/AU2008298017B2/en not_active Ceased
- 2008-09-10 WO PCT/EP2008/007418 patent/WO2009033649A1/en active Application Filing
- 2008-09-10 MX MX2010002736A patent/MX2010002736A/es not_active Application Discontinuation
- 2008-09-10 US US12/733,645 patent/US8877814B2/en not_active Expired - Fee Related
- 2008-09-10 MX MX2010002734A patent/MX2010002734A/es not_active Application Discontinuation
- 2008-09-10 TW TW097134701A patent/TW200927087A/zh unknown
- 2008-09-10 EP EP08801984A patent/EP2200598A1/de not_active Withdrawn
- 2008-09-10 CA CA2699213A patent/CA2699213A1/en not_active Abandoned
- 2008-09-10 SI SI200830530T patent/SI2200600T1/sl unknown
- 2008-09-10 JP JP2010524393A patent/JP5612473B2/ja not_active Expired - Fee Related
- 2008-09-10 AR ARP080103938A patent/AR071728A1/es not_active Application Discontinuation
- 2008-09-10 ES ES08801986.4T patent/ES2510565T3/es active Active
- 2008-09-10 CA CA2699210A patent/CA2699210A1/en not_active Abandoned
- 2008-09-10 ES ES08801985.6T patent/ES2604945T3/es active Active
- 2008-09-10 CN CN200880106975A patent/CN101795679A/zh active Pending
- 2008-09-10 MX MX2010002735A patent/MX2010002735A/es unknown
- 2008-09-10 EP EP12006826.7A patent/EP2548552B1/de active Active
- 2008-09-10 AU AU2008298018A patent/AU2008298018C1/en not_active Ceased
- 2008-09-10 AU AU2008298016A patent/AU2008298016B2/en not_active Ceased
- 2008-09-10 TW TW097134699A patent/TW200918042A/zh unknown
- 2008-09-10 ES ES12006826.7T patent/ES2562709T3/es active Active
2010
- 2010-02-22 ZA ZA2010/01264A patent/ZA201001264B/en unknown
- 2010-02-22 ZA ZA2010/01262A patent/ZA201001262B/en unknown
- 2010-02-22 ZA ZA2010/01263A patent/ZA201001263B/en unknown
- 2010-02-22 ZA ZA2010/01261A patent/ZA201001261B/en unknown
2011
- 2011-09-08 RU RU2011137131/15A patent/RU2011137131A/ru not_active Application Discontinuation
2014
- 2014-06-12 JP JP2014121269A patent/JP5784189B2/ja not_active Expired - Fee Related
- 2014-06-12 JP JP2014121268A patent/JP5784188B2/ja not_active Expired - Fee Related
- 2014-09-30 US US14/501,438 patent/US20150018425A1/en not_active Abandoned
2016
- 2016-10-12 US US15/291,527 patent/US20170027885A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP2200599A1 (de)	2010-06-30
JP5613053B2 (ja)	2014-10-22
CA2699209A1 (en)	2009-03-19
AR070025A1 (es)	2010-03-10
ES2562709T3 (es)	2016-03-07
ES2596262T3 (es)	2017-01-05
US8877814B2 (en)	2014-11-04
SI2200600T1 (sl)	2012-03-30
JP5784189B2 (ja)	2015-09-24
JP2010539117A (ja)	2010-12-16
AU2008298015A1 (en)	2009-03-19
ES2377253T3 (es)	2012-03-23
AU2008298018B2 (en)	2012-01-19
US9498450B2 (en)	2016-11-22
EP2200599B1 (de)	2016-08-31
CA2699207A1 (en)	2009-03-19
ZA201001261B (en)	2011-08-31
EP2200600A1 (de)	2010-06-30
WO2009033650A1 (en)	2009-03-19
EP2548552A2 (de)	2013-01-23
AU2008298017B2 (en)	2012-03-01
AU2008298016A1 (en)	2009-03-19
ZA201001262B (en)	2011-07-27
TW200918042A (en)	2009-05-01
JP5563460B2 (ja)	2014-07-30
CN101801365A (zh)	2010-08-11
MX2010002734A (es)	2010-04-01
CN101801366A (zh)	2010-08-11
JP2010539115A (ja)	2010-12-16
MX2010002735A (es)	2010-04-01
US20150018425A1 (en)	2015-01-15
AU2008298016B2 (en)	2012-02-02
JP2010539118A (ja)	2010-12-16
KR20100052557A (ko)	2010-05-19
EP2386299B1 (de)	2016-07-13
DK2200600T3 (da)	2012-01-23
EP2548552B1 (de)	2015-11-18
US9468610B2 (en)	2016-10-18
AR071728A1 (es)	2010-07-14
KR20100052556A (ko)	2010-05-19
CN101795679A (zh)	2010-08-04
ES2604945T3 (es)	2017-03-10
EP2200600B1 (de)	2011-11-09
EP2386299A3 (de)	2012-05-02
TW200927087A (en)	2009-07-01
AU2008298017A1 (en)	2009-03-19
AU2008298018A1 (en)	2009-03-19
CA2699210A1 (en)	2009-03-19
JP5784188B2 (ja)	2015-09-24
JP2014221766A (ja)	2014-11-27
KR20100052559A (ko)	2010-05-19
EP2203163B1 (de)	2014-08-27
ATE532507T1 (de)	2011-11-15
BRPI0816712A2 (pt)	2016-11-08
CN101835469A (zh)	2010-09-15
MX2010002733A (es)	2010-04-09
BRPI0816690A2 (pt)	2016-11-01
JP5612473B2 (ja)	2014-10-22
CA2699213A1 (en)	2009-03-19
TW200922544A (en)	2009-06-01
JP2014221767A (ja)	2014-11-27
PT2200600E (pt)	2012-02-17
EP2386299A2 (de)	2011-11-16
WO2009033652A1 (en)	2009-03-19
US20100298440A1 (en)	2010-11-25
JP5563461B2 (ja)	2014-07-30
US20110077304A1 (en)	2011-03-31
US20100298441A1 (en)	2010-11-25
EP2200598A1 (de)	2010-06-30
JP2010539116A (ja)	2010-12-16
RU2011137131A (ru)	2013-03-20
US20110086916A1 (en)	2011-04-14
AU2008298018C1 (en)	2012-08-16
EP2548552A3 (de)	2013-10-16
ZA201001263B (en)	2011-07-27
ES2510565T3 (es)	2014-10-21
EP2203163A1 (de)	2010-07-07
MX2010002736A (es)	2010-04-01
ZA201001264B (en)	2011-07-27
PL2200600T3 (pl)	2012-04-30
WO2009033651A1 (en)	2009-03-19
KR20100052558A (ko)	2010-05-19
AU2008298015B2 (en)	2012-03-22
AR070026A1 (es)	2010-03-10
US20170027885A1 (en)	2017-02-02
WO2009033649A1 (en)	2009-03-19

Publication	Publication Date	Title
HRP20120046T1 (hr)	2012-02-29	Nerameksan za uporabu kod liječenja subakutnog tinitusa
EA201071054A1 (ru)	2011-04-29	Твердый препарат, растворяющийся во рту
DK1656122T4 (da)	2013-03-11	Transdermale lægemiddeltilberedninger med kombinationer af aktive stoffer til behandling af Parkinsons syge
BRPI0618211B8 (pt)	2021-05-25	composição farmacêutica contendo pregabalina para dosagem uma vez ao dia e uso do referido composto
RU2014145557A (ru)	2016-06-10	Комбинированный состав, содержащий многокомпонентную сфероидальную таблетку (мкст), заключенную в твердую капсулу, и способ его приготовления
AR079208A2 (es)	2012-01-04	Inhibidores de la actividad de proteina tirosina quinasa, composicion y uso de dichos inhibidores para la preparacion de un medicamento para tratar una enfermedad, trastorno o condicion oftalmica
JP2009541443A5 (de)	2010-08-12
RU2010116863A (ru)	2011-12-10	Бупропиона гидробромид и его терапевтические применения
EA200801926A1 (ru)	2009-04-28	Таблетки парацетамола с быстрым высвобождением
WO2008144061A3 (en)	2009-02-12	Novel combinations comprising a phosphodiesterase-5 inhibitor and their use
AR082493A1 (es)	2012-12-12	Formulaciones a base de nalbufina, y sus utilizaciones
AR060019A1 (es)	2008-05-21	Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
BR112014009438A2 (pt)	2017-04-11	composição farmacêutica para administração oral, e, método de preparação da composição farmacêutica para administração oral
ATE505203T1 (de)	2011-04-15	Pharmazeutische kombination aus aliskiren und valsartan
CR10801A (es)	2009-07-03	Composicion farmaceutica en forma de microesferas recubiertas para la liberacion modificada de un relajante muscular y un aine
WO2007143163A3 (en)	2008-07-24	Pharmaceutical compositions for sustained release of phenyephrine
RU2014142025A (ru)	2016-05-10	Препарат длительного высвобождения для снижения частоты мочеиспускания и способ его применения
CL2009001841A1 (es)	2011-02-18	Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
MX2013005482A (es)	2013-08-29	Composicion farmaceutica que contiene sales de citrato y bicarbonato, y su uso para el tratamiento de la cistinuria.
RS51211B (sr)	2010-12-31	Primena formulacija koje sadrže kapa-opioid receptor-agoniste za tretman disocijativnih poremećaja
RU2019109695A (ru)	2020-10-26	Лекарственная форма для пролонгированного ослабления симптомов
CL2009000330A1 (es)	2009-08-21	Composicion farmaceutica que comprende microcapsulas de sabor enmascarado con un nucleo de ranitidina y al menos dos recubrimientos sobre el; tabla de rapida desintegracion oral; metodo para preparar la composicion farmaceutica; metodo para preparar la tableta, util para tratar o prevenir trastornos gastrointestinales.
UY30126A1 (es)	2007-09-28	Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
AR051589A1 (es)	2007-01-24	Agentes terapeuticos
ATE460934T1 (de)	2010-04-15	Pharmazeutische zubereitungen von ciprofloxacin